Uncategorized
iVeena Delivery Systems Receives FDA Orphan Drug Designation for IVMED-80 for the Treatment of Keratoconus
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems is awarded orphan drug designation for IVMED-80, a novel eye-drop therapy treating keratoconus